Bi, Yaodan
Zhu, Yinchao
Tang, Shuai
Huang, Yuguang
Article History
Received: 4 July 2023
Accepted: 18 July 2023
First Online: 18 August 2023
Declarations
:
: As per the regulations outlined in People's Republic of China’s "Notice on the Implementation of Ethical Review Measures for Life Science and Medical Research," our study falls under the exemption criteria specified in Sect. 4 of the regulation. Therefore, ethics approval was not required for this research, as it met the following conditions:1. Exemption Premise: The study exclusively utilized publicly available data, specifically summary-level data from GWAS, which does not involve sensitive personal information, pose harm to individuals, or compromise their privacy.2. Exemption Provision: Our research adheres to the exemption circumstances outlined in Sect. 4 of the regulation:- We utilized lawfully obtained publicly available data for our analysis.- The data used in this study were fully anonymized, ensuring the privacy and confidentiality of individuals.- Our research focuses on analyzing existing data and does not involve interventions, human biological samples, or activities related to reproductive cloning, genetic manipulation, or germ cells.Due to the nature of our study and its compliance with the exemption criteria, we did not require explicit ethics approval. While informed consent was not obtained from individual participants since the study involved publicly available data, we ensured that all data accessed and analyzed were fully de-identified and complied with the terms of use and guidelines provided by the data source. We affirm that this research was conducted in accordance with the applicable laws, regulations, and ethical standards.
: Not applicable.
: The authors declare no competing interests.